MitrAssist
Latest round
- Series C
Last raised
- Sep 2023
Total raised
- $170M
Investors
- 9
About MitrAssist
Established in 2017 and based in Shanghai, China, MitrAssist is a medical device company that focuses on the research and development of cardiovascular medical devices. On September 22, 2023, MitrAssist signed a CNY 2 billion R&D industrialization project for cardiovascular products and high-value consumables with Hefei City. The company's main products include interventional heart valve (mitral valve, tricuspid valve and aortic valve) treatment products, interventional coronary drug balloon products, and interventional heart failure treatment products.
Who invested in MitrAssist
9 investors across 2 rounds
See all investors in MitrAssist
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MitrAssist
Who invested in MitrAssist?
MitrAssist has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MitrAssist raised?
MitrAssist has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MitrAssist last raise money?
MitrAssist's most recent round on record is a Series C, in Sep 2023.
What does MitrAssist do?
Established in 2017 and based in Shanghai, China, MitrAssist is a medical device company that focuses on the research and development of cardiovascular medical devices.
Where is MitrAssist headquartered?
MitrAssist is headquartered in Shanghai, China.
Which VCs invest in companies like MitrAssist?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at MitrAssist's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like MitrAssist? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.